August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for…
April 30, 2018
By stretching the amount of time proteins can be simulated in their natural state of wiggling and gyrating, a team of researchers at Colorado State University— using supercomputers at the San Diego Supercomputer Center at UC San Diego and the Pittsburgh Supercomputing Center—has identified a critical protein structure that could…
May 29, 2020
A $1 million gift from the John and Mary Tu Foundation is helping to increase the number of people tested for COVID-19, as well as develop new ways to track and treat the virus.
October 13, 2022
The University of California San Diego today announced the 2022 recipients of the Revelle Medal, which recognizes current and former faculty members for sustained, distinguished and extraordinary service to the university.
October 29, 2024
UC San Diego will honor five individuals as recipients of the 2024 Revelle Medal, a prestigious award recognizing sustained, distinguished and extraordinary service to campus. The 2024 Revelle Medal recipients are: Fan Chung Graham, Stephan Haggard, Douglas Richman, M.D., Robert Schooley, M.D. and Jan B. Talbot.
July 12, 2018
New research has uncovered a protein that enables the replication of arenaviruses, lethal pathogens spreading in West Africa. The research identified DDX3 as a key factor through its unexpected ability to dismantle normal human immune system defenses. The study may pave the way to new therapeutic treatments for arenaviruses and…
February 24, 2022
Bioengineering Alumnus on COVID-19 Antiviral Pill Development Team Jacobs School of Engineering alumnus Britton Boras earned a Ph.D. in bioengineering in 2015, conducting research with Professor Andrew McCulloch on multi-scale modeling of biological systems. Now a Senior Principal Scientist at Pfizer, Boras uses the modeling skills he honed at UC…
August 5, 2020
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.
January 25, 2018
…and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus — and blocked transmission of the virus to mouse fetuses. Researchers at University of California San Diego School of Medicine, with colleagues in Brazil and elsewhere, say their findings…
June 17, 2020
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
